MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NeoGenomics Company Profile (NASDAQ:NEO)

Consensus Ratings for NeoGenomics (NASDAQ:NEO) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.80 (13.10% upside)

Analysts' Ratings History for NeoGenomics (NASDAQ:NEO)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016Roth CapitalInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Benchmark Co.Boost Price TargetBuy$8.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Janney Montgomery ScottInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Craig HallumBoost Price TargetBuy$8.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha